Tempus AI
Genomic testing plus one of the largest multimodal clinical datasets, used for AI models and trial matching.
Tempus sells xT (648-gene), xR (RNA), xF/xM (liquid, MRD), TIME trial matching, Tempus ECG-AF and other algorithms, and owns Ambry Genetics (germline).
Pages like this
not linked directly; found by shared links- CompanyFoundation Medicine (Roche)
Shares A global federated real-world evidence network at regulatory grade, Emulate combination trials from real-world data to triage which ones to run, A single calibrated tumour mutational burden across all sequencing panels, Label every targetable mutation as truncal or branch on the report.
- CompanyOwkin
Shares Digital twins and virtual control arms, A pre-competitive consortium to train a shared multimodal cancer foundation model, Patient-level multimodal foundation models for treatment selection, Pathology & radiology foundation models.
- TermNext-generation sequencing (NGS)
Shares A single calibrated tumour mutational burden across all sequencing panels, Label every targetable mutation as truncal or branch on the report, Every tumour sequencing report lists open, nearby, matched trials pulled live, Every tumour genomic report machine-readable and deposited nationally.
- CompanyGuardant Health
Shares Label every targetable mutation as truncal or branch on the report, Every tumour sequencing report lists open, nearby, matched trials pulled live, Every tumour genomic report machine-readable and deposited nationally, Weak real-world evidence and registries.
- IdeaFederated training of pathology and radiology models across hospitals
Shares A pre-competitive consortium to train a shared multimodal cancer foundation model, Pathology & radiology foundation models, AI that is built but not validated or deployed, Data silos.
- CompanyCancer Commons
Shares Trial matching inside the electronic record at the moment a treatment is chosen, AI trial matching & clinical decision support, Patients lack understanding, navigation and agency, Data silos.
- IdeaPool every immunotherapy trial's biomarker data into one commons
Shares Patient-level multimodal foundation models for treatment selection, Pathology & radiology foundation models, AI that is built but not validated or deployed, Data silos.
- CompanyCaris Life Sciences
Shares Every tumour sequencing report lists open, nearby, matched trials pulled live, Every tumour genomic report machine-readable and deposited nationally, Comprehensive genomic profiling.